0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Dravet Syndrome Treatment Market 2024-2028 - Product Thumbnail Image

Dravet Syndrome Treatment Market 2024-2028

  • Report
  • June 2024
  • 178 Pages
  • Global
From
EUR$2,500USDGBP
From
EUR$2,999USDGBP
From
EUR$2,690USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Lennox-Gastaut Syndrome Treatment Market 2024-2028 - Product Thumbnail Image

Lennox-Gastaut Syndrome Treatment Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
EUR$2,500USDGBP
Epilepsy Therapeutic Market in APAC 2024-2028 - Product Thumbnail Image

Epilepsy Therapeutic Market in APAC 2024-2028

  • Report
  • January 2024
  • 156 Pages
  • Asia Pacific
From
EUR$2,500USDGBP
From
EUR$4,899USDGBP
Epidural Abscess Treatment Market Report 2025 - Product Thumbnail Image

Epidural Abscess Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,150USDGBP
From
EUR$4,750USDGBP
Loading Indicator